Breakthrough T1D CEO Dr. Aaron Kowalski shares some of the exciting type 1 diabetes (T1D) research he's looking forward to hearing about at #ADA2026!
Be sure to stay tuned for more coverage, and join us on June 10 at 6pm ET for a mid-year mission update!
You can tune in across our social media channels--you won't want to miss it!
I grew up in apartheid S Africa, where muzzling of speech and encroachment on academic freedom were the norm. I came to the US to pursue a career in science. I never thought that at this stage of my career, I would ever experience my youth again. #StandUpForScience#ADA#ADA2026
Diabetes researchers ejected from conference after criticizing White House. The editor of ADA journal Steve Kahn was nondisruptivedly handing out his recent editorial in ADA journal that criticized Trump NIH policies. Big mistake by @AmDiabetesAssn https://t.co/BcRCS793PY
Diabetes researchers, including the editor of a flagship journal, ejected from conference after criticizing Trump's "dismantling" of biomedical research https://t.co/eOdj6m6iGp
In case you didn't get a chance to read the reprint.
Misguided Brushes of a Pen Continue to Dismantle and Destroy Biomedical Research in the United States: We Can No Longer Afford Complacency and Fear. We Must All Act Now! https://t.co/mU33UrkcPW #ADASciSessions
If the goal was to stir controversy, leadership executed yesterday's opening of #ADASciSessions brilliantly. But we rather doubt this is what ADA had in mind. Sending police after distinguished scientists is not good.
HT: @medpagetoday@KristinaMFiore
https://t.co/pYYMDaZKqz
A growing contingent of doctors say they are wary of federal health guidance under Robert F. Kennedy Jr.—and they are forming a parallel public-health universe https://t.co/ubphbKuIqb via @WSJ